Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Long-Term Investments (2020 - 2025)

Historic Long-Term Investments for Adma Biologics (ADMA) over the last 6 years, with Q3 2025 value amounting to $8.8 million.

  • Adma Biologics' Long-Term Investments rose 5119.44% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.8 million, marking a year-over-year increase of 5119.44%. This contributed to the annual value of $5.7 million for FY2024, which is 2113.49% up from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' Long-Term Investments is $8.8 million, which was up 5119.44% from $9.1 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Long-Term Investments registered a high of $9.1 million during Q2 2025, and its lowest value of $2.5 million during Q2 2021.
  • Moreover, its 5-year median value for Long-Term Investments was $5.0 million (2022), whereas its average is $5.4 million.
  • In the last 5 years, Adma Biologics' Long-Term Investments surged by 9304.46% in 2021 and then plummeted by 1698.27% in 2024.
  • Adma Biologics' Long-Term Investments (Quarter) stood at $4.1 million in 2021, then increased by 17.27% to $4.8 million in 2022, then fell by 2.1% to $4.7 million in 2023, then increased by 21.13% to $5.7 million in 2024, then surged by 55.52% to $8.8 million in 2025.
  • Its Long-Term Investments stands at $8.8 million for Q3 2025, versus $9.1 million for Q2 2025 and $8.2 million for Q1 2025.